Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Lida Kalmanti, Michael Lauseker, M. C. Muller, +21

Leukemia

Hematological MalignancyOncologyClinical TrialsMyeloid NeoplasiaCml-study Iv +6

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

Andreas Hochhaus, Andreas Reiter, Heyko Skladny, +7

Blood

Laboratory tests of iron status: correlation or common sense?

Jan Hastka, Jean-Jacques Lasserre, A Schwarzbeck, +2

Clinical Chemistry

AnemiaTranslational MedicineBone Marrow FailureIron MetabolismMedicine +13

Fatal Liver Failure Associated with Valproate Therapy in a Patient with Friedreich's Disease: Review of Valproate Hepatotoxicity in Adults

S. A. König, Martin Schenk, C. Sick, +5

Epilepsia

Detection of <i>Aspergillus</i> DNA in Cerebrospinal Fluid from Patients with Cerebral Aspergillosis by a Nested PCR Assay

Michael Hummel, Karim Kentouche, S. Niggemann, +6

Journal of Clinical Microbiology

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Thomas Ernst, Jim Hoffmann, Philipp Erben, +5

Haematologica

Mixed-phenotype Acute LeukemiaGeneticsGenetic EpidemiologyKinase InhibitorsPathology +15

Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure

Alice Fabarius, Claudia Haferlach, M. C. Muller, +7

Haematologica

Mixed-phenotype Acute LeukemiaGeneticsImmunologyPathologyPhiladelphia Chromosome +16

Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib

Paul La Rosée, Susanne Holm-Eriksen, Helmut König, +12

Haematologica

Hematological MalignancyTumor BiologyChronic Myeloid LeukemiaOncologyLymphoblastic Leukemia Patients +13

Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib

Alice Fabarius, Michael Giehl, Blanca Rebacz, +7

Haematologica

Roferon (rIFN-α _2a ) Is More Immunogenic Than Intron A (rIFN-α _2b ) in Patients with Chronic Myelogenous Leukemia

Peter von Wussow, R. Hehlmann, T. Hochhaus, +7

Journal of Interferon Research